227 related articles for article (PubMed ID: 18560618)
1. Handing over the baton: connecting medicinal chemistry with process R&D.
Federsel HJ
Drug News Perspect; 2008 May; 21(4):193-9. PubMed ID: 18560618
[TBL] [Abstract][Full Text] [Related]
2. Process R&D under the magnifying glass: organization, business model, challenges, and scientific context.
Federsel HJ
Bioorg Med Chem; 2010 Aug; 18(16):5775-94. PubMed ID: 20621486
[TBL] [Abstract][Full Text] [Related]
3. Chemical process research and development in the 21st century: challenges, strategies, and solutions from a pharmaceutical industry perspective.
Federsel HJ
Acc Chem Res; 2009 May; 42(5):671-80. PubMed ID: 19338294
[TBL] [Abstract][Full Text] [Related]
4. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
Federsel HJ
Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
[TBL] [Abstract][Full Text] [Related]
5. Looking forward in pharmaceutical process chemistry.
Davies IW; Welch CJ
Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
[TBL] [Abstract][Full Text] [Related]
6. Helping science to succeed: improving processes in R&D.
Sewing A; Winchester T; Carnell P; Hampton D; Keighley W
Drug Discov Today; 2008 Mar; 13(5-6):227-33. PubMed ID: 18342798
[TBL] [Abstract][Full Text] [Related]
7. Strategies and tactics for optimizing the Hit-to-Lead process and beyond--a computational chemistry perspective.
Manly CJ; Chandrasekhar J; Ochterski JW; Hammer JD; Warfield BB
Drug Discov Today; 2008 Feb; 13(3-4):99-109. PubMed ID: 18275907
[TBL] [Abstract][Full Text] [Related]
8. The integration of process R&D in drug discovery--challenges and opportunities.
Federsel HJ
Comb Chem High Throughput Screen; 2006 Feb; 9(2):79-86. PubMed ID: 16475965
[TBL] [Abstract][Full Text] [Related]
9. Enantiomeric separation and determination of absolute stereochemistry of asymmetric molecules in drug discovery: building chiral technology toolboxes.
McConnell O; Bach A; Balibar C; Byrne N; Cai Y; Carter G; Chlenov M; Di L; Fan K; Goljer I; He Y; Herold D; Kagan M; Kerns E; Koehn F; Kraml C; Marathias V; Marquez B; McDonald L; Nogle L; Petucci C; Schlingmann G; Tawa G; Tischler M; Williamson RT; Sutherland A; Watts W; Young M; Zhang MY; Zhang Y; Zhou D; Ho D
Chirality; 2007 Sep; 19(9):658-82. PubMed ID: 17390370
[TBL] [Abstract][Full Text] [Related]
10. Early chemical development at Legacy Wyeth Research.
O'Brien MK; Kolb M; Connolly TJ; McWilliams JC; Sutherland K
Drug Discov Today; 2011 Jan; 16(1-2):81-8. PubMed ID: 21111844
[TBL] [Abstract][Full Text] [Related]
11. The graphical representation of ADME-related molecule properties for medicinal chemists.
Ritchie TJ; Ertl P; Lewis R
Drug Discov Today; 2011 Jan; 16(1-2):65-72. PubMed ID: 21074634
[TBL] [Abstract][Full Text] [Related]
12. Selecting and controlling API crystal form for pharmaceutical development--strategies and processes.
Yin SX; Grosso JA
Curr Opin Drug Discov Devel; 2008 Nov; 11(6):771-7. PubMed ID: 18946842
[TBL] [Abstract][Full Text] [Related]
13. Process Analytical Technology (PAT): batch-to-batch reproducibility of fermentation processes by robust process operational design and control.
Gnoth S; Jenzsch M; Simutis R; Lübbert A
J Biotechnol; 2007 Oct; 132(2):180-6. PubMed ID: 17559961
[TBL] [Abstract][Full Text] [Related]
14. Compound scale-up at the discovery-development interface.
Nikitenko AA
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):729-40. PubMed ID: 17117683
[TBL] [Abstract][Full Text] [Related]
15. New opportunities for biocatalysis: making pharmaceutical processes greener.
Woodley JM
Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
[TBL] [Abstract][Full Text] [Related]
16. Strategic use of preparative chiral chromatography for the synthesis of a preclinical pharmaceutical candidate.
Leonard WR; Henderson DW; Miller RA; Spencer GA; Sudah OS; Biba M; Welch CJ
Chirality; 2007 Sep; 19(9):693-700. PubMed ID: 17354260
[TBL] [Abstract][Full Text] [Related]
17. ROCK: the Roche medicinal chemistry knowledge application - design, use and impact.
Mayweg A; Hofer U; Schnider P; Agnetti F; Galley G; Mattei P; Lucas M; Boehm HJ
Drug Discov Today; 2011 Aug; 16(15-16):691-6. PubMed ID: 21439402
[TBL] [Abstract][Full Text] [Related]
18. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
Schirlin D; Galvan M; Le Fur G
Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
[TBL] [Abstract][Full Text] [Related]
19. Searching for scalable processes: addressing the challenges in times of increasing complexity.
Federsel HJ
Curr Opin Drug Discov Devel; 2003 Nov; 6(6):838-47. PubMed ID: 14758755
[TBL] [Abstract][Full Text] [Related]
20. A chemogenomic approach to discovering target-selective drugs.
Janzen WP; Hodge CN
Chem Biol Drug Des; 2006 Jan; 67(1):85-6. PubMed ID: 16492154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
